All Viruses articles – Page 4
-
NewsNew single-dose, temperature-stable rabies vaccines could expand global access
Researchers have discovered a new way to make human rabies vaccines that could greatly expand access to immunization across the globe. The new method creates shots that are temperature-stable—meaning they don’t need to be stored at cold temperatures.
-
NewsNext-gen anti-bacterial and anti-viral surface modification technology inspired by Korean mussels
Researchers have successfully developed a next-generation surface modification technology with anti-bacterial and anti-viral contamination properties.While maximizing the bactericidal effect, a polydopamine layer, combined with an antibiotic, inhibits the adsorption of coronavirus.
-
NewsKoala stress linked to virus infection risk
Researchers have revealed a clear relationship between stress and increased disease risk in koalas in South East Queensland and on the New South Wales North Coast.The study tracked the level of koala retrovirus (KoRV) in groups of captive and wild koalas.
-
NewsStudy identifies hotspots of disease-carrying ticks in Illinois
Scientists analyzed the distribution of three potentially harmful tick species in Illinois, identifying regions of the state with higher numbers of these ticks and, therefore, at greater risk of infection with multiple tick-borne diseases.
-
News‘We need to prepare for a growing number of West Nile virus infections,’ experts warn
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among healthcare providers in Europe. A clinical insight aims to equip medical professionals with the knowledge needed to recognize and manage this emerging disease.
-
NewsBird flu outbreak in house cats: high-risk but survival possible
Cats can survive bird flu if they receive early care and antiviral treatment with oseltamivir and need not be euthanized in every case, a new study shows.
-
NewsNIH grant aims for childhood vaccine against HIV
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. Source: NIAID Transmission electron micrograph ...
-
NewsTuberculosis vulnerability of people with HIV: a viral protein implicated
Tuberculosis accounts for one in three deaths among people living with HIV. A new study highlights the key role played by Tat 2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsAdverse event profiles following HPV vaccination in males
The safety profile among male recipients of human papillomavirus (HPV) vaccination remains a critical evidence gap. A new study presents the first systematic safety evaluation of Gardasil 9 and Gardasil in male recipients.
-
NewsHPV integration: Moving from carcinogenesis mechanisms to clinical applications
The clinical significance of HPV integration into the host genome is substantial, particularly in cervical cancer screening programs. Integration testing has emerged as a valuable triage tool for detecting high-grade cervical intraepithelial neoplasia (CIN III+).
-
NewsScientists identify four ways our bodies respond to COVID-19 vaccines
Researchers tracked individuals’ antibody levels after vaccinations and identified four distinct patterns of immune response after the first booster, suggesting that monitoring how antibody levels change over time could assist in identifying individuals at greater risk of infection.
-
NewsDisease experts upgrade sentinel chicken system to create forecast for West Nile virus
An interdisciplinary team of experts have created a statistical model that accurately predicts the activity of West Nile virus in an area up to six months in advance. The model was trained using two decades of sentinel chicken data.
-
NewsHow HIV enters the genome – researchers identify previously unknown mechanism
Researchers have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids (R-loops) as molecular signposts for the virus.
-
NewsTargeted delivery of microRNA sponge short-hairpin RNA via VIR-inspired biotechnical vector
The Vir-inspired Biotechnical Vector (VIBV) is a novel hybrid platform that combines viral and non-viral elements with nanotechnology to enable personalized, tumor-specific gene therapy.
-
NewsAI-powered CRISPR could lead to faster gene therapies, study finds
A new AI tool can help scientists better plan gene-editing experiments. CRISPR-GPT acts as a gene-editing “copilot” supported by AI to help researchers — even those unfamiliar with gene editing — generate designs, analyze data and troubleshoot design flaws.
-
NewsU.S. Public Health Service releases new guidelines on occupational HIV exposure and postexposure prophylaxis
The CDC, on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to Human Immunodeficiency Virus (HIV) and Recommendations for Postexposure Prophylaxis (PEP).
-
NewsScientists link waning Japanese encephalitis immunity to higher dengue severity
Scientists have found that waning immunity to Japanese encephalitis virus (JEV) may increase the risk of more severe dengue disease in humans. The study highlights how fading vaccine protection from one virus can unintentionally affect the body’s response to another.
-
NewsResearch identifies immune response that controls Oropouche infection and prevents neurological damage
Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.
-
NewsResearchers find a way to use antibodies to direct T cells to kill Cytomegalovirus-infected cells
Researchers have found a new way to prompt the immune system to kill cells infected with cytomegalovirus (CMV). They did this by engineering antibodies that direct the immune system’s T-cells to kill cells infected with the virus.